Rodrigo Martino

Rodrigo Martino publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rodrigo Martino sits on this spectrum.

Rodrigo Martino D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rodrigo Martino sits on this spectrum.

Overview

Best Publications

• Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

  Rodrigo Martino;Simona Iacobelli;Ronald Brand;Thekla Jansen

  478
  Citations

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

  Sally Arai;Mukta Arora;Tao Wang;Tao Wang;Stephen R. Spellman

  475
  Citations

• Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

  Koen Van Besien;Fausto R. Loberiza;Ruta Bajorunaite;James O. Armitage

  441
  Citations

• Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus

  Hans H. Hirsch;Rodrigo Martino;Katherine N. Ward;Michael Boeckh

  396
  Citations

• Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

  P. Ljungman;K. N. Ward;B. N. Crooks;A. Parker

  388
  Citations

• Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

  Theo De Witte;David Bowen;Marie Robin;Luca Malcovati

  371
  Citations

• Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

  ZiYi Lim;Ronald Brand;Rodrigo Martino;Anja van Biezen

  362
  Citations

• Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies After Allogeneic Stem-Cell Transplantation

  John E. Levine;Thomas Braun;Samuel L. Penza;Patrick Beatty

  321
  Citations

• Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

  David Valcárcel;Rodrigo Martino;Dolores Caballero;Jesus Martin

  302
  Citations

• Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies

  Rodrigo Martino;Rocío Parody Porras;Nuria Rabella;John V. Williams

  296
  Citations

• Allogeneic Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia With 17p Deletion: A Retrospective European Group for Blood and Marrow Transplantation Analysis

  Johannes Schetelig;Anja van Biezen;Ronald Brand;Dolores Caballero

  285
  Citations

• Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

  M. Eapen;S. A. Giralt;M. M. Horowitz;J. P. Klein

  283
  Citations

• Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

  Lori Muffly;Marcelo C. Pasquini;Michael Martens;Ruta Brazauskas

  283
  Citations

• Early Detection of Toxoplasma Infection by Molecular Monitoring of Toxoplasma gondii in Peripheral Blood Samples after Allogeneic Stem Cell Transplantation

  Rodrigo Martino;Stéphane Bretagne;Hermann Einsele;Johan Maertens

  277
  Citations

• Toxoplasmosis After Hematopoietic Stem Cell Transplantation

  R Martino;J Maertens;S Bretagne;M Rovira

  273
  Citations

• Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

  Jan Styczynski;Lidia Gil;Gloria Tridello;Per Ljungman;Per Ljungman

  269
  Citations

• Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

  Rodrigo Martino;Maricel Subirá;Montserrat Rovira;Carlos Solano

  269
  Citations

• Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.

  José A Pérez-Simón;Panagiotis D Kottaridis;Rodrigo Martino;Charles Craddock

  266
  Citations

• Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning

  P Dreger;R Brand;J Hansz;D Milligan

  265
  Citations

• Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/ Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

  Anna Sureda;Carme Canals;Reyes Arranz;Dolores Caballero

  261
  Citations